Tom Schrader
Analyst
UBS/BTIG
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Tom Schrader
Tom Schrader is recorded as Analyst at UBS/BTIG. Tom Schrader has spoken on 2 investor events across 1 company, most recently for Acumen Pharmaceuticals, Inc. on September 16, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
UBS/BTIG
Analyst
Transcript header (unverified)
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.